REDCARE PHARMACY NV (RDC.DE) Stock Price, Forecast & Analysis
Europe - FRA:RDC - NL0012044747 - Common Stock
RDC.DE Key Statistics, Chart & Performance
The current stock price of RDC.DE is 61.15 EUR. In the past month the price decreased by -29.75%. In the past year, price decreased by -63.51%.
RDC.DE Competitors/Peers
Related stock screener links
About RDC.DE
Company Profile
Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. The company is headquartered in Sevenum, Limburg and currently employs 2,659 full-time employees. The company went IPO on 2016-10-13. The firm focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The firm is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.
Company Info
REDCARE PHARMACY NV
Erik de Rodeweg 11/13
Sevenum LIMBURG NL
Employees: 1827
REDCARE PHARMACY NV / RDC.DE FAQ
Can you describe the business of REDCARE PHARMACY NV?
Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. The company is headquartered in Sevenum, Limburg and currently employs 2,659 full-time employees. The company went IPO on 2016-10-13. The firm focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The firm is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.
What is the stock price of REDCARE PHARMACY NV today?
The current stock price of RDC.DE is 61.15 EUR. The price decreased by -0.97% in the last trading session.
What is the dividend status of REDCARE PHARMACY NV?
RDC.DE does not pay a dividend.
How is the ChartMill rating for REDCARE PHARMACY NV?
RDC.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the Price/Earnings (PE) ratio of REDCARE PHARMACY NV (RDC.DE)?
REDCARE PHARMACY NV (RDC.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.8).
Can you provide the growth outlook for REDCARE PHARMACY NV?
The Revenue of REDCARE PHARMACY NV (RDC.DE) is expected to grow by 25.61% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
How many employees does REDCARE PHARMACY NV have?
REDCARE PHARMACY NV (RDC.DE) currently has 1827 employees.
RDC.DE Technical Analysis
RDC.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to RDC.DE. While RDC.DE seems to be doing ok healthwise, there are quite some concerns on its profitability.
RDC.DE Financial Highlights
Over the last trailing twelve months RDC.DE reported a non-GAAP Earnings per Share(EPS) of -1.8. The EPS decreased by -39.61% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.88% | ||
| ROE | -7.01% | ||
| Debt/Equity | 0.62 |
RDC.DE Forecast & Estimates
14 analysts have analysed RDC.DE and the average price target is 155.65 EUR. This implies a price increase of 154.54% is expected in the next year compared to the current price of 61.15.
For the next year, analysts expect an EPS growth of 49.41% and a revenue growth 25.61% for RDC.DE